AlphaStar Capital Management LLC Has $515,000 Stake in UnitedHealth Group Incorporated $UNH

Key Points

• AlphaStar Capital Management LLC cut its UNH holding by 90.9% in Q4, selling 15,620 shares and leaving it with 1,560 shares worth $515,000.
• UnitedHealth delivered a Q1 beat (EPS $7.23 vs. $6.76) and raised its 2026 outlook, the stock rallied about 14.5%, and analysts have largely lifted price targets with a consensus "Moderate Buy" target near $378.88.
• Insider activity: Optum CEO Patrick Conway sold 800 shares for roughly $284,000, trimming his ownership by about 4.3%.

AlphaStar Capital Management LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 90.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,560 shares of the healthcare conglomerate's stock after selling 15,620 shares during the quarter. AlphaStar Capital Management LLC's holdings in UnitedHealth Group were worth $515,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of UNH. Beacon Financial Strategies CORP bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Joseph Group Capital Management acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. Foster Dykema Cabot & Partners LLC boosted its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 34 shares during the period. 1248 Management LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $29,000. Finally, Holos Integrated Wealth LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $29,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm's stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares of the company's stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on UNH shares. Leerink Partners upped their price target on shares of UnitedHealth Group from $345.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 22nd. Royal Bank Of Canada boosted their price target on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 22nd. Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 22nd. Truist Financial reissued a "buy" rating and set a $395.00 price target (up from $370.00) on shares of UnitedHealth Group in a research report on Wednesday, April 22nd. Finally, Mizuho dropped their price target on shares of UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $378.88.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and outlook lift — UnitedHealth reported a sizable Q1 beat, raised its 2026 outlook and earlier popped ~14.5% on the results, giving the company fresh earnings momentum that supports higher valuations. UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
• Positive Sentiment: Goldman Sachs endorsement — Goldman added UNH to its U.S. conviction list, a notable buy-side vote that can attract institutional flows and lend support to the stock. Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
• Positive Sentiment: Strong recent momentum vs. peers — UNH slightly outperformed Humana in April’s managed-care rally, signaling resilience vs. a key peer during a positive sector backdrop. UnitedHealth or Humana: Which Managed Care Stock Had the Healthiest Returns in April?
• Positive Sentiment: Buy thesis discussion — Analyst commentary is probing whether UNH is now undervalued after the rally, which can attract long-term buy interest if investors buy the growth/Optum story. Is UnitedHealth Stock an Undervalued Stock to Buy?
• Neutral Sentiment: CVS valuation context — Coverage noting CVS trades much cheaper than UNH highlights relative valuation differences that may shift some value-oriented flows away from UNH. CVS Earnings Are Coming. Why the Stock Is No Longer a Value Trap.
• Neutral Sentiment: Macro/ETF context — A note on the Invesco S&P 500 Revenue ETF is tangential but relevant for portfolio allocation decisions that could affect large-cap names like UNH. Should Invesco S&P 500 Revenue ETF (RWL) Be on Your Investing Radar?
• Negative Sentiment: Competitor strength — Cigna reported strong results led by Evernorth, and an improving peer picture can pressure market-share expectations or investor preference within the sector. Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
• Negative Sentiment: Insider trimming — Optum CEO Patrick Conway sold about $284k of UNH stock after earnings (his first 2026 sale), which can be read as modest profit-taking and may add to near-term selling pressure. UnitedHealth Stock Has Rallied Since Earnings. One Top Insider Is Trimming His Stake.

UnitedHealth Group Price Performance

Shares of UNH opened at $369.29 on Monday. The firm has a market capitalization of $335.39 billion, a PE ratio of 27.89, a PEG ratio of 1.59 and a beta of 0.64. The company's 50-day moving average is $299.45 and its 200-day moving average is $316.79. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $409.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company's revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio is presently 66.77%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.